Between the 1970s and 1985, Bayer sold blood products to hemophiliacs and unknowingly infected between 6,000 and 10,000 customers in the United States with HIV and hepatitis C. When the company laboratories realized that the blood products were contaminated, the financial investment in the products was considered too high to destroy the inventory. The company misrepresented the results of their own research and “dumped” the contaminated products to overseas markets in Asia and Latin America. Bayer paid out 600 million dollars to settle lawsuits brought by thousands of American victims.
Goldberg, Suzanne. May 23rd 2003. The Guardian. Bayer Division ‘knowingly sold’ HIV-infected Protien.